𝛼SK or Search

ENTITY

AstraZeneca (AZN LN)

203

Analysis

Health Care • United Kingdom

AstraZeneca is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was formed in 1999 through the merger of Astra AB and Zeneca Group PLC and is headquartered in Cambridge, UK.

more

Refresh

bullish•AstraZeneca

•09 Aug 2026 14:48

Primer: AstraZeneca (AZNN MM) - Aug 2026

AstraZeneca is a global biopharmaceutical company with a strong focus on specialty medicines in oncology, rare diseases, and...

αSK Primers

100 Views

Share

bullish•AstraZeneca

•19 May 2026 19:08

Primer: AstraZeneca (AZN SS) - May 2026

AstraZeneca is poised for significant growth, driven by its robust oncology portfolio and a deep, late-stage pipeline with over 20 potential...

αSK Primers

107 Views

Share

bullish•AstraZeneca

•23 Sep 2025 10:44

Primer: AstraZeneca PLC (AZN LN) - Sep 2025

AstraZeneca is a global biopharmaceutical powerhouse, strongly positioned for sustained growth driven by its leadership in Oncology and...

αSK Primers

140 Views

Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x